Real-World Data on Effectiveness and Safety of First-Line Use of Caplacizumab in Italian Centers for the Treatment of Thrombotic Thrombocytopenic Purpura: The Roscapli Study.

Autor: Fianchi, Luana1 (AUTHOR), Bonanni, Matteo1 (AUTHOR), Borchiellini, Alessandra2 (AUTHOR) aborchiellini@cittadellasalute.to.it, Valeri, Federica2 (AUTHOR), Giuffrida, Gaetano3 (AUTHOR), Grasso, Stephanie3 (AUTHOR), Fozza, Claudio4 (AUTHOR), Ponta, Michele4 (AUTHOR), Tiscia, Giovanni L.5 (AUTHOR) elvira.grandone@unifgg.it, Grandone, Elvira5 (AUTHOR), Vianelli, Nicola6 (AUTHOR) alessandra.dedola@aosp.bo.it, Dedola, Alessandra6 (AUTHOR), Pirozzi, Teresa7 (AUTHOR), Sacco, Monica8 (AUTHOR), Lancellotti, Stefano7 (AUTHOR), De Cristofaro, Raimondo7,8 (AUTHOR) raimondo.decristofaro@unicatt.it
Zdroj: Journal of Clinical Medicine. Nov2024, Vol. 13 Issue 21, p6561. 9p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje